Acute Lymphoblastic Leukaemias (ALL) Recruiting Phase 2 / 3 Trials for Pyridoxine (DB00165)

Also known as: Acute Lymphoblastic Leukemia(ALL) / Acute Leukaemia, Lymphoblastic / Leukemia, Acute Lymphoblastic / Acute Lymphoblastic Leukemias / Acute Lymphoblastic Leukemia / Acute Lymphoblastic Leukaemia / Lymphoblastic Leukemia, Acute / Acute Lymphoblastic Leukemia (ALL) / Acute Leukemia, Lymphoblastic / Leukaemia, Lymphoblastic, Acute / Leukemia, Lymphoblastic, Acute / Acute lymphoblastic leukemia with failed remission / Leukemia lymphoblastic acute / Lymphoid leukaemia, acute / Acute lymphoid leukaemia / Lymphoid leukemia, acute / Acute lymphoid leukemia / ALL / Leukaemia lymphoblastic acute / Acute lymphocytic leukemia / Acute lymphatic leukaemia / Leukaemias acute lymphocytic / Acute lymphatic leukemia / Acute lymphocytic leukaemia

IndicationStatusPhase
DBCOND0073466 (Acute Lymphoblastic Leukaemias (ALL))Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03593304Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in Acute Lymphoblastic Leukaemia PatientsPrevention